The Adaptive COVID-19 Treatment Trial or ACTT has entered the new stage of its trial, ACTT2, which will study the potential coronavirus drug remdesivir in combination with baricitinib or placebo.
Related Posts
The Adaptive COVID-19 Treatment Trial or ACTT has entered the new stage of its trial, ACTT2, which will study the potential coronavirus drug remdesivir in combination with baricitinib or placebo.